|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM275540693 |
003 |
DE-627 |
005 |
20250222062953.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2017 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2017.08.020
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0918.xml
|
035 |
|
|
|a (DE-627)NLM275540693
|
035 |
|
|
|a (NLM)28882618
|
035 |
|
|
|a (PII)S1521-6616(17)30635-6
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Massaad, Michel J
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a DOCK8 and STAT3 dependent inhibition of IgE isotype switching by TLR9 ligation in human B cells
|
264 |
|
1 |
|c 2017
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 28.01.2019
|
500 |
|
|
|a Date Revised 28.01.2019
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Letter
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a CpG
|
650 |
|
4 |
|a DOCK8
|
650 |
|
4 |
|a Hyper IgE Syndrome
|
650 |
|
4 |
|a IgE synthesis
|
650 |
|
4 |
|a STAT3
|
650 |
|
7 |
|a CD40 Antigens
|2 NLM
|
650 |
|
7 |
|a DOCK8 protein, human
|2 NLM
|
650 |
|
7 |
|a Guanine Nucleotide Exchange Factors
|2 NLM
|
650 |
|
7 |
|a Oligodeoxyribonucleotides
|2 NLM
|
650 |
|
7 |
|a ProMune
|2 NLM
|
650 |
|
7 |
|a STAT3 Transcription Factor
|2 NLM
|
650 |
|
7 |
|a STAT3 protein, human
|2 NLM
|
650 |
|
7 |
|a TLR9 protein, human
|2 NLM
|
650 |
|
7 |
|a Toll-Like Receptor 9
|2 NLM
|
650 |
|
7 |
|a Interleukin-4
|2 NLM
|
650 |
|
7 |
|a 207137-56-2
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin E
|2 NLM
|
650 |
|
7 |
|a 37341-29-0
|2 NLM
|
700 |
1 |
|
|a Cangemi, Brittney
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Al-Herz, Waleed
|e verfasserin
|4 aut
|
700 |
1 |
|
|a LeFranc, Gérard
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Freeman, Alexandra
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Baxi, Sachin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Keles, Sevgi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Metin, Ayse
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dasouki, Majid
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sobh, Ali
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kanariou, Maria
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Al-Sukaiti, Nashat
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ozen, Ahmet
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ochs, Hans
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chatila, Talal A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Manis, John P
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Geha, Raif
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 183(2017) vom: 04. Okt., Seite 263-265
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:183
|g year:2017
|g day:04
|g month:10
|g pages:263-265
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2017.08.020
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 183
|j 2017
|b 04
|c 10
|h 263-265
|